Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Intraoperative Blood Pressure Management and Dexamethasone on Patient's Outcomes After Lung Cancer Surgery: A 2 × 2 Factorial Randomized Controlled Trial

NCT04209218 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT04209218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04209218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Intraoperative Blood Pressure Management and Dexamethasone on Patient's Outcomes After Lung Cancer Surgery: A 2 × 2 Factorial Randomized Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 7, 2020
Completion date
December 31, 2029
Enrollment
1,988 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure management, dexamethasone, lung cancer, overall survival, postoperative complications, surgery